Breast Reconstruction Market

Market Overview

The global breast reconstruction market was valued at USD 462.98 million in 2021, and it is anticipated to reach USD 790.2 million by 2030 at a CAGR of 6.12%.

Breast reconstruction is a surgical operation that involves reconstructing and increasing the shape and size of the breast, intending to appear as natural as is practicable. An increase in the frequency of breast cancer surgeries, the number of breast-restoration alternatives, and an increase in awareness about the reconstruction of breasts all point to an increase in the market for breast cancer reconstruction. Reconstructive surgery for breast cancer is performed after breast cancer operations such as lumpectomy, mastectomy, or surgery to correct any other congenital disabilities. This procedure improves the woman's appearance and helps her regain her self-confidence. The expansion of the global market for breast reconstruction can be attributed to several significant factors, including the availability of highly qualified plastic surgeons, the development of new technologies, and safer surgical procedures.

A growing number of women are opting to undergo breast reconstruction following a lumpectomy or mastectomy to attain a more natural appearance in their breasts due to the rising incidence of breast cancer and the associated increases.

Market Dynamics

Global Breast Reconstruction Market Drivers

• Increasing people's awareness regarding the therapy of breast reconstruction

After a mastectomy, some patients go ahead and get breast reconstruction surgery. It is mainly attributable to rising worries and expanding awareness of the safety and effectiveness of reconstructive operations. This pattern is visible in rich and developing countries that observe an ascent in their populations' standard of living.

The rise in awareness is attributable to market participants, stakeholders, and independent groups like the American Society of Plastic Surgeons (ASPS). Breast Reconstruction Awareness was a campaign established by the American Society of Plastic Surgeons (ASPS) in collaboration with the Plastic Surgery Foundation to engage and educate women about breast reconstruction after a breast cancer diagnosis. The breast cancer loop will not be closed until a woman is told of the various breast reconstruction options. The campaign's primary goal was to educate women, family members, and the media on this point.

• Increasing cases of breast cancer

The global breast reconstruction market is anticipated to be driven by an increase in breast cancer prevalence, breast reconstruction surgeries, and a surge in demand for acellular dermal matrix. In 2020, 2.3 million women were diagnosed with breast cancer, and 685,000 people died from the disease worldwide, according to the World Health Organization (WHO). With an age-adjusted incidence rate of up to 25.8 per 100,000 women and a fatality rate of 12.7 per 100,000, breast cancer is the most common malignancy among women in India. Invasive breast cancer strikes 1 in 8 American women (about 13%) at some point in their lifetime.

Breast reconstruction following mastectomy is becoming more and more popular worldwide. In 2000, 78,832 breast reconstruction procedures were carried out, according to the American Society of Plastic Surgeons (ASPS). In 2017, it climbed to 106,295.

An acellular dermal matrix supports the breast implant. Positive results are seen, particularly in individuals with rapid reconstruction following mastectomy. The number of surgeons who use acellular dermal matrices for breast augmentation and reconstruction has increased as more people learn about the advantages of these materials in these procedures.

Global Breast Reconstruction Market Opportunities

• Implants were developed using 3D printing.

The advent of 3D-printed implants may present considerable market expansion prospects. BellaSeno and Evonik, both German businesses, have partnered to create 3D breast implant technology. BellaSeno will forgo silicone implants, which have caused severe safety issues, and instead employ Evonik's Resomer bioresorbable polymer in its Senella breast scaffolds.

BellaSeno intended to begin the first Stenella scaffold human clinical studies with Resomer in Germany in 2019. For both commercial and medical applications, Evonik has provided its Resomer polymer. Using liposuctioned body fat from the patient, the scaffolds are intended to direct the growth of the natural tissue. After augmentation, reconstruction, and revision surgery, this substance is intended to be applied. Natural breast tissue gradually replaces this as the body gradually reabsorbs it. With the help of this technique, silicone implants are avoided along with the risks and issues they bring, such as capsular contracture, rupture, and deflation. Additionally, BellaSeno GmbH announced in December 2021 the release of first-in-human data for their 3D-printed biodegradable and extremely porous Stenella scaffold loaded with an autologous fat transplant to treat a chest deformity in a 22-year-old patient with severe pectus excavatum.

Global Breast Reconstruction Market Restraints

• Several other non-surgical techniques

Some women favour breast reconstruction surgery after a mastectomy. Others choose against it because they are unaware of it or have other health problems, like obesity, skinniness, or changes in blood flow dynamics. These women can choose personalized breast prosthesis, going flat, or other options for breast reconstruction. For individuals who have had a single mastectomy, a custom breast prosthesis can recreate the woman's precise contour and achieve symmetry with the entire breast. These prosthetics range in price from around $100 to over $500 for high-quality items, making them far more affordable than breast reconstruction surgery. The breast reconstruction market is significantly constrained by the availability of alternatives, particularly non-surgical techniques.

Segmental Analysis

The global market for breast reconstruction is divided into segments based on product, procedure, placement, shape, end-user, and region. The product categories include acellular dermal matrix, tissue expanders, and breast implants. Due to silicone-based implants, which are the most popular because they feel more like genuine breast tissues, the breast implants market category has the most significant market share.

The segments covered by the procedure are immediate, delayed, and revision. Due to its aesthetic effect, cost-effectiveness, and psychological repercussions, an immediate reconstruction procedure is a superior alternative, and most women choose it.

Sub-muscular insertion, sub-glandular insertion, and dual-plane insertion are the three segments according to placement. It takes less time and is better to implant subcutaneously; this segment dominates the market.

Based on shape, the market is bifurcated into round and anatomical implants. While round implants are the most excellent option if you want to stimulate the upper portion of the breasts, anatomical implants make the breasts look natural.

The market is divided into hospitals, specialized surgery centres, and clinics based on end-users. The hospital segment dominates the market because of the increased funding by the government to improvise breast cancer treatment procedures further. 

According to region, the market is divided into North America, Europe, Asia-Pacific and Latin America, the Middle East & Africa. North America dominates the market.

Regional Analysis

According to region, the market is divided into North America, Europe, Asia-Pacific and Latin America, the Middle East & Africa.

There is no question that the North America region held the lion's share of the market. There has been a sharp rise in the number of women diagnosed with breast cancer, an increase in people's awareness of the many different kinds of breast reconstruction procedures, and the Food and Drug Administration has granted more approvals for breast reconstruction products. These are some of the most critical factors contributing to the rapid market expansion in this region. According to Breastcancer.Org, breast reconstruction surgery that involves the use of implants is one of the most prevalent forms of such procedures that is conducted in the United States. In 2019, over 107 thousand breast reconstruction surgeries were performed in the United States, with almost 80 per cent of those procedures involving breast implants.

When it came to CAGRs, the Asia-Pacific region was anticipated to develop more quickly than any other region, and it did so consistently throughout the forecast period (2022-2030).

Recent Developments

• In 2022, the US Food and Drug Administration (FDA) approved a new MENTOR Memory Gel boost breast implant manufactured by Mentor Worldwide LLC (Johnson & Johnson).

• In May 2022, GC Aesthetics®, Inc. (GCA), a medical technology firm specializing in providing Healthcare Aesthetic Solutions, recently announced the debut of an Innovative Nipple Areola Complex (NAC) Reconstruction Implant called FixNipTM NRI.

• In February 2022, Establishment Labs Holdings Inc., a multinational medical technology company focused on enhancing women's health and wellbeing, particularly in breast aesthetics and reconstruction, recently announced that it has sold more than two million Motiva Implants® globally.

Breast Reconstruction Market Segmentation

By Product

• Acellular Dermal Matrix
• Tissue Expanders
• Breast Implants

By Procedure

• Immediate
• Delayed
• Revision

By Placement

• Sub-Muscular Insertion
• Sub-Glandular Insertion
• Dual-Plane Insertion

By Shape

• Round Implants
• Anatomical Implants

By End-Users

• Hospitals
• Specialized Surgery Centres
• Clinics

By Region

• North America
• Europe
• Asia-Pacific
• LAMEA